These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3879313)

  • 21. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 22. Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis.
    Salusky IB; Brill J; Oppenheim W; Goodman WG
    Semin Nephrol; 1989 Mar; 9(1):37-42. PubMed ID: 2740652
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy.
    Coburn JW
    Kidney Int Suppl; 1990 Sep; 29():S54-61. PubMed ID: 2214548
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological suppression of hyperparathyroidism in patients treated by periodical hemodialysis. Histological, hormonal, biochemical and radiological study].
    Brancaccio D; Faccini JM; Graziani G; Banfi G; Pedoja G; Watson L
    Minerva Nefrol; 1976; 23(2):149-53. PubMed ID: 1087389
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vitamin-D-resistant hypophosphatemic rickets].
    Velásquez-Jones L; Dorantes-Alvarez L; Ajuria ML
    Bol Med Hosp Infant Mex; 1984 Oct; 41(10):561-8. PubMed ID: 6095879
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic interstitial nephritis in two siblings.
    Sakarcan A
    J S C Med Assoc; 2003 Oct; 99(10):305-6. PubMed ID: 14621661
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous versus oral calcitriol therapy: is there a clinical difference?
    Lantz JP
    Nephrol News Issues; 1992 Sep; 6(9):38-41. PubMed ID: 1407072
    [No Abstract]   [Full Text] [Related]  

  • 31. Do patients who are treated with calcitriol for renal osteodystrophy also need vitamin D3 therapy?
    Mehls O
    Pediatr Nephrol; 1995 Apr; 9(2):136. PubMed ID: 7794703
    [No Abstract]   [Full Text] [Related]  

  • 32. Protocol of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Chinchilli VM; Boyle RM; Massie MD; Jennings SS; Kohaut EC; Dresner IG; Tejani A; Arbus GS
    J Pediatr; 1990 Feb; 116(2):S17-21. PubMed ID: 2405130
    [No Abstract]   [Full Text] [Related]  

  • 33. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
    Arora N; Sandroni S; Moles K
    Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histological typing of renal osteodystrophy].
    Zhu J
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):723-4. PubMed ID: 10451940
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronic renal failure].
    Kazama JJ; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():226-8. PubMed ID: 16279636
    [No Abstract]   [Full Text] [Related]  

  • 37. History and organization of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Brouhard BH; Chinchilli VM; Greifer I
    J Pediatr; 1990 Feb; 116(2):S3-7. PubMed ID: 2405133
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differential effects of 1,25-hydroxycholecalciferol in uremic osteodystrophy].
    Tarchini R; Pacchiarotti P; Figus S; Perilli A; Baldelli S; Mioli V
    Minerva Nefrol; 1981; 28(2):147-50. PubMed ID: 6895244
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.
    Salusky IB; Goodman WG
    Kidney Int; 1995 Sep; 48(3):657-65. PubMed ID: 7474649
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of renal osteodystrophy with calcitriol in patients on maintenance haemodialysis].
    Tomanovski V
    Srp Arh Celok Lek; 1994; 122(5-6):136-8. PubMed ID: 17977409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.